North American M&A performance declines for the third

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
61
North American M&A performance declines for the third consecutive quarter

ARLINGTON, Va., June 25, 2018 (GLOBE NEWSWIRE) -- During the second quarter of 2018, the North American M&A market recorded its worst-ever performance since the launch of the Quarterly Deal Performance Monitor (QDPM) by Willis Towers Watson 10 years ago. According to the study results, which are based on share-price performance, North American deal makers, on average, significantly underperformed their Regional Index by 6.2 percentage points during the second quarter. This marks the third consecutive quarter in which North American M&A performance was negative, having declined 3.3 percentage points in the first quarter of 2018 and 3.9 percentage points in the last quarter of 2017.   

The study also found that North American deal makers focused more on domestic deals, as the percentage of overseas deals for North American acquirers during the first half of 2018 declined sharply, representing just 13% of acquisitions, compared with 20% for the same period in 2017.

“The increasing focus on domestic acquisitions in North America is being fueled partly by the U.S. tax reform law changes, which are encouraging repatriation of capital back to the U.S. This, in turn, makes it easier for U.S. firms to target and invest profits in domestic acquisitions,” said Jim McKay, director, M&A services, Willis Towers Watson. “With that said, the overall M&A performance in North America is down over the past nine months. As a result, targeting domestic acquisitions is not proving to be profitable so far.”

Additional findings revealed by the Willis Towers Watson global study in partnership with Cass Business School, the City, University of London’s business school include:

  • Deal types of all sizes, valued from $100 million to over $10 billion, have underperformed the Global Index on average.
  • Over a one-year rolling period, acquirers have underperformed overall by an average of 2.7 percentage points.
  • Quick cross-sector and cross-border deals all underperformed the Global Index (by 3.2 percentage points, 5.4 percentage points and 6.6 percentage points respectively), a clear trend reversal from the previous quarter.
  • The Consumer Staples, Health Care and Telecommunications sectors outperformed their respective indices.
  • The Consumer Product and Services, Energy & Power, Financial, Industrial, Material and High Technology sectors underperformed their sector indices.

“The deal-making slowdown and increasing North American acquirer focus on domestic deals is likely to continue given the ongoing economic uncertainty,” said McKay. “Interestingly, the poor performances that have followed completed deals in North America suggest investors right now have very little margin for error. Looking primarily at domestic deals could lead to more competition for a smaller pool of targets. The bottom line is North American deal makers should look for the best deals and not limit themselves to just domestic targets.”

Willis Towers Watson QDPM methodology

  • All analysis is conducted from the perspective of the acquirer.
  • Share-price performance within the quarterly study is measured as a percentage change in share price from six months prior to the announcement date to the end of the quarter.
  • All deals where the acquirer owned less than 50% of the shares of the target after the acquisition were removed; hence, no minority purchases have been considered. All deals where the acquirer held more than 50% of target shares prior to the acquisition have been removed; hence, no remaining purchases have been considered.
  • Only completed M&A deals with a value of at least $100 million that meet the study criteria are included in this research.
  • Deal data are sourced from Thomson Reuters.

About Willis Towers Watson M&A

Willis Towers Watson’s M&A practice combines our expertise in risk and human capital to offer a full range of M&A services and solutions covering all stages of the M&A process. We have particular expertise in the areas of planning, due diligence, risk transfer and post-transaction integration, areas that define the success of any transaction.

About Willis Towers Watson

Willis Towers Watson (NASDAQ: WLTW ) is a leading global advisory, broking and solutions company that helps clients around the world turn risk into a path for growth. With roots dating to 1828, Willis Towers Watson has over 40,000 employees serving in more than 140 countries. We design and deliver solutions that manage risk, optimize benefits, cultivate talent, and expand the power of capital to protect and strengthen institutions and individuals. Our unique perspective allows us to see the critical intersections between talent, assets and ideas — the dynamic formula that drives business performance. Together, we unlock potential. Learn more at willistowerswatson.com.

Media contacts

Ed Emerman +1 609 275 5162 eemerman@eaglepr.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 24

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
Laars Welcomes Women in Manufacturing to Facility Tour

Updated Category News Views 6

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 7

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 15

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 2

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Canada and Ukraine Fortify Defense with UGV Partnership

Updated Category News Views 7

New Defense Fronts: Canada and Ukraine Join Forces October 13, 2026, marks an important day in Ottawa's defense narrative with Dominion Dynamics and Ukraine's TENCORE kicking off a robust partnership. They're not just collaborating; they're plugging into each other's strengths to build TerMIT uncrewed ground vehicles (UGVs) on Canadian soil. These aren't gizmos you find...

Continue Reading
Fluence Energy Faces Major Lawsuit Amid $3B Loss

Updated Category News Views 11

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 2

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Montesodi 2023: A Fresh Chapter in Chianti Excellence

Updated Category News Views 7

A Glass Filled with History and Nature's Whimsy When you pour a glass of Montesodi 2023, you’re not just tasting wine but a story—a saga that blends Tuscany’s rich vineyard history with last year's unpredictable weather. Marchesi Frescobaldi, a name that’s seen it all over its thousand years, has once again shown us how resilience and tradition can marry with...

Continue Reading
Quark Baby's Milk Warmer Debut at Vancouver & Dubai

Updated Category News Views 15

An Unconventional Pitch for Baby Gear Quark Baby is strutting its stuff not just in Vancouver but all the way in Dubai. Yeah, we're talking about a milk warmer hitting two major expos. What's the deal with an award-winning brand from Vancouver making so much noise? From October 17-18, they're home-court at The Baby Show Vancouver, and by October 22-24, they're in Dubai at...

Continue Reading

Top 5 Most Recently Viewed Articles

Seadrill and Petrobras Unite for Major $498 Million Deal

Updated Category News Views 246

Seadrill Secures Major Contract with Petrobras HAMILTON, Bermuda - Seadrill Limited (NYSE: SDRL), an offshore drilling contractor with a market capitalization of $2.46 billion and a trading price of $37.31, has successfully won a crucial contract with Brazilian oil giant Petrobras for its ultra-deepwater drillship, West Tellus. This significant agreement emerged from a...

Continue Reading
Investigation Launched into Acadia Healthcare Company’s Practices

Updated Category News Views 143

Acadia Healthcare Company Under Investigation Law Offices of Howard G. Smith has announced that it is conducting an investigation on behalf of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and its investors. This examination is prompted by potential violations of federal securities laws following serious allegations concerning the company’s operational practices....

Continue Reading
Cousins Maine Lobster Dishes New Lobster Roll Flight

Updated Category News Views 7

A Bite-Sized Maine Experience Get a whiff of this: Cousins Maine Lobster is rollin' out something that'll make your taste buds do a jig. They call it the Lobster Roll Flight, and it's about to shake things up for seafood lovers everywhere. Dropping on July 1st nationwide, this offering lets foodies sample three of Cousins' star rolls—Maine, Connecticut, and Garlic...

Continue Reading
Innovative Knee Support Product Designed for Pain Relief

Updated Category News Views 250

Introducing an Innovative Knee Support Solution In today's world, many individuals suffer from knee pain, often due to issues such as arthritis or weakened quadricep muscles. Recognizing this challenge, a doctor of physical therapy and an inventive team have come together to create a groundbreaking solution called the KNEE SUPPORT. This innovative product stands out as a...

Continue Reading
Recent Forecast Changes for TELA Bio Following Third Quarter Results

Updated Category News Views 185

Recent Forecast Changes for TELA Bio TELA Bio Inc (NASDAQ: TELA) has recently reported its third-quarter earnings, which presented a mix of results. The company incurred a loss of 19 cents per share, slightly better than analysts had anticipated at 20 cents. However, TELA Bio's quarterly sales totaled $20.7 million, falling short of estimates that predicted $21.8 million....

Continue Reading